A commentary on "The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials" (Int J Surg 2020; 75:116-127)
- PMID: 32105897
- DOI: 10.1016/j.ijsu.2020.02.019
A commentary on "The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials" (Int J Surg 2020; 75:116-127)
Keywords: Commentary; Meta-analysis; Randomized control trials.
Comment on
-
The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.Int J Surg. 2020 Mar;75:116-127. doi: 10.1016/j.ijsu.2020.01.142. Epub 2020 Jan 31. Int J Surg. 2020. PMID: 32014597
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
